首页> 外文期刊>Revista Brasileira de Otorrinolaringologia >nm23 protein expression in metastatic and non-metastatic tongue squamous cell carcinoma
【24h】

nm23 protein expression in metastatic and non-metastatic tongue squamous cell carcinoma

机译:nm23蛋白在转移性和非转移性舌鳞癌中的表达

获取原文
           

摘要

Oral squamous cells carcinoma (OSCC) shows unfavorable prognosis due to its invasion potential around the neighboring tissues and the elevated incidence of metastasis. AIM: the present paper aims at analyzing the immunohistochemical expression of the nm23 protein in metastatic and non-metastatic SCCs of tongue. METHODS: the immuno-expression to the nm23-hl protein was diagnosed in 35 tongue SCC (15 of which exhibiting metastasis). Nm23-hl immuno-scores were assigned as follow: score 0 = absent, 1 = focal and 2 = diffuse expression. RESULTS: The Fisher's exact test was performed and there was no statistical difference between the nm23-hl immuno-scores and the tongue SCCs studied cases (p=0.365), although 66.7% of metastatic cases presented negative nm23-hl expression. CONCLUSIONS: Protein nm23 was not associated with a positiveness for tongue SCC without metastasis. Thus, several others factors inherent to host and malignancy can be associated with the mechanisms that suppress the metastatic process in this disease.
机译:口腔鳞状细胞癌(OSCC)由于其在周围组织周围的浸润潜能和转移的发生率较高,因此预后不良。目的:本研究旨在分析nm23蛋白在舌转移性和非转移性SCC中的免疫组织化学表达。方法:在35例舌鳞癌中诊断出对nm23-hl蛋白的免疫表达(其中15例出现转移)。 Nm23-hl免疫评分的分配如下:评分0 =缺失,1 =局灶性,2 =弥散表达。结果:进行了Fisher's精确检验,nm23-hl免疫评分与舌SCCs研究病例之间无统计学差异(p = 0.365),尽管66.7%的转移性病例nm23-hl表达阴性。结论:nm23蛋白与无转移的舌鳞癌阳性无关。因此,宿主和恶性肿瘤固有的其他一些因素可能与抑制该疾病转移过程的机制有关。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号